Jared David Malbin
CIK: 0002155319
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VBIO
Valion Bio, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Malbin Jared David
Malbin Jared David (SEC CIK 0002155319) files insider reports with the SEC as Director of Valion Bio, Inc. (VBIO).
Signal8 holds 1 ownership filing by Malbin Jared David, a Form 3, filed on Sep 17, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Malbin Jared David's filings is in SAN ANTONIO, TX.
Other insiders filing for Valion Bio, Inc. (VBIO)
- Zikria Dean, Interim CEO
- Wolf Lisa G, COO & CFO
- Jensen Thomas, Director
- Lackey Melinda, General Counsel & SVP of Legal